PT  - JOURNAL ARTICLE
AU  - Tasnim Momoniat
AU  - Duha Ilyas
AU  - Sunil Bhandari
TI  - ACE inhibitors and ARBs: Managing potassium and renal function
AID  - 10.3949/ccjm.86a.18024
DP  - 2019 Sep 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 601--607
VI  - 86
IP  - 9
4099  - http://www.ccjm.org/content/86/9/601.short
4100  - http://www.ccjm.org/content/86/9/601.full
SO  - Cleve Clin J Med2019 Sep 01; 86
AB  - Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) are used primarily to treat hypertension and are also useful for conditions such as heart failure and chronic kidney disease, independent of their effect on blood pressure. This article reviews the indications for ACE inhibitors and ARBs and offers advice for managing their adverse effects, particularly declining renal function and hyperkalemia.